Show
Sort by
-
- Journal Article
- A1
- open access
Decoy receptor 1 (DCR1) promoter hypermethylation and response to irinotecan in metastatic colorectal cancer
-
WRN promoter CpG island hypermethylation does not predict more favorable outcomes for patients with metastatic colorectal cancer treated with irinotecan-based therapy
-
Recent insights into the pathophysiology of omental metastases
-
Association of DNA promoter hypermethylation of decoy receptor 1 (DCR1) with poor response to irinotecan in metastatic colorectal cancer
-
Evidence-based medicine: the time has come to set standards for staging